Skip to main content
Fig. 6 | Cancer Imaging

Fig. 6

From: Radiomic nomogram based on MRI to predict grade of branching type intraductal papillary mucinous neoplasms of the pancreas: a multicenter study

Fig. 6

Clinical utility evaluation of the radiomic signature and the radiomic nomogram using DCA curves. Evaluation in the training cohort (a), external validation cohort 1 (b), and external validation cohort 2 (c). The y-axis shows the net benefit. The x-axis shows the threshold probability. The highest net benefit was gained using the radiomic nomogram (red line) compared with the radiomic signature (blue line), the treat-all strategy (gray line), and the treat-none strategy (horizontal black line)

Back to article page